Patent Assignment
Reel/Frame 043341/0420
Change of Name
Recorded: 2017-07-26
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Modulation of Growth Hormone Receptor Expression and Insulin-Like Growth Factor Expression
Modulation of Growth Hormone Receptor Expression and Insulin-Like Growth Factor Expression
Oligomeric Compounds Comprising 4'-Thionucleosides for Use in Gene Modulation
Conjugates for Use in Hepatocyte Free Uptake Assays
Modification of MYD88 Splicing Using Modified Oligonucleotides
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Modulation of C-Reactive Protein Expression
Improved Process for the Synthesis of 2'-O-Substituted Purine Nulceosides
Modulation of EIF4E-BP2 Expression
Antibacterial 4,5-Substituted Aminoglycoside Analogs Having Multiple Substituents
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.